J Mitra & Co

What J Mitra & Co does

J. Mitra & Co. Pvt. Ltd. is a privately-held Indian manufacturer of in-vitro diagnostic (IVD) test kits, headquartered in New Delhi and operating since 1969. The company designs, manufactures, and supplies diagnostic kits and laboratory instrumentation across four core technology platforms: Chemiluminescent Immunoassay (CLIA), ELISA, Rapid Test (including 4th generation flow-through technology), and Fluorescence Immunoassay, supplemented by Blood Grouping Sera and Confirmatory (Western blot) Tests. Its portfolio spans infectious disease screening (HIV, hepatitis B/C, dengue, malaria, tuberculosis, COVID-19, typhoid, scrub typhus, chikungunya, leptospira), cardiac markers, hormones (thyroid, fertility, diabetes), tumor markers, autoimmune and allergy panels, supported by approximately 70+ products and 55+ patents. Notable technical assets include proprietary acridinium ester-based chemiluminescent microparticle immunoassay chemistry and the iQuant CLIA Analyzer developed in partnership with HTIC, IIT Madras.

The company monetizes primarily through one-time product sales of IVD kits and reagents to B2B customers, combined with hardware sales of laboratory instruments that generate recurring consumables revenue. Sales are executed via a multi-tier distribution architecture: stockists for self-test products, super distributors with cold-chain capability for temperature-sensitive kits, an agent network across 40+ international markets, and direct procurement through India's Government e-Marketplace (GEM) portal. Customer segments include hospitals, diagnostic laboratories, government public health programs, blood banks, and international agencies/NGOs. The business is family-owned and operated by the Mahajan family (Jatin Mahajan, Managing Director; Lalit Mahajan, Chairman) with no institutional outside capital.

Operationally, the company holds ISO 9001:2015, EN ISO 13485:2016, and CE Mark certifications for quality and international market access, alongside Drug Controller General of India (DCGI) approvals for specific indications including blood-bank screening. The company has received multiple industry recognitions including "India's Greatest Brand" (2019), "Most Emerging Company in Diagnostics & Reagents" (2020), and "Biotech Company of the Year" (2026). Notably, the company has not publicly disclosed revenue, employee count detail beyond the 101-250 range, or capital structure, which limits external visibility into commercial scale.

Name

J Mitra & Co

Legal name

J. Mitra & Co. Pvt. Ltd.

Website

https://jmitra.co.in

Company type

Private

Founded year

1969

Operating status

Operating

Headcount range

101–250 employees

Short description

J. Mitra & Co. is a privately-held Indian IVD diagnostic kit manufacturer, founded 1969 and headquartered in New Delhi, producing CLIA, ELISA, rapid, and fluorescence immunoassay test kits plus laboratory instrumentation for hospitals, diagnostic labs, blood banks, government health programs, and international agencies across 40+ countries.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics (IVD) Manufacturing

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Hematology & Coagulation Diagnostics (HLAHAAAB), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• In-vitro diagnostics
• IVD diagnostic kits
• Chemiluminescent immunoassay
• Rapid test kits
• Blood grouping sera

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. IVD Diagnostic Kit Sales: Sale of in-vitro diagnostic test kits including Rapid Test Kits, ELISA Test Kits, CLIA Test Kits, Fluorescence Immunoassay Test Kits, Confirmatory Tests, and Blood Grouping Sera. One-time product sales model with recurring reagent and consumables purchases.
2. Instrumentation Sales: Sale of laboratory instruments including ELISA Readers, ELISA Washers, CLIA Analyzers (iQuant), and Fluorescence Instruments for diagnostic testing.
3. International Export: Export of manufactured IVD products to international agencies and non-governmental organizations across 40+ countries through agent network.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

J Mitra & Co. manufactures in-vitro diagnostic (IVD) test kits and instruments across multiple technology platforms including Chemiluminescent Immunoassay (CLIA), ELISA, Rapid Test, and Fluorescence Immunoassay. Its product portfolio covers 70+ diagnostic tests for infectious diseases (HIV, Hepatitis, Dengue, Malaria, Typhoid, COVID-19), cardiac markers, hormones, fertility, thyroid, tumor markers, autoimmune conditions, blood grouping sera, and confirmation testing. The company also offers laboratory instrumentation including the proprietary iQuant CLIA Analyzer co-developed with HTIC, IIT Madras.

Product overview

J Mitra & Co is an IVD kit manufacturer offering a diversified portfolio of diagnostic products organized across multiple technology platforms. The core offerings include CLIA (Chemiluminescent Immunoassay) Product Range covering 46 tests across categories like Anemia, Cardiac Markers, Dengue, Hormones, Thyroid, Bone Metabolism, Reproductive Hormones, Infectious Diseases, Inflammation Monitoring, Tumor Markers, Vector-Borne, and Allergens; Rapid Test Kits for point-of-care testing of 24 diseases including Celiac, Chikungunya, COVID-19, Dengue, Hepatitis B/C, HIV, Malaria, Scrub Typhus, and Typhoid; ELISA Test Kits for 27 laboratory-based tests; Confirmatory Tests for HIV verification; Blood Grouping Sera; Fluorescence Immunoassay Test Kits; and Instrumentation Range including ELISA Reader & Washer, Fluorescence Instruments, and proprietary CLIA Analyzer (iQuant) developed with HTIC IIT Madras. The products range from screening tests to confirmatory and quantitative diagnostic solutions serving both clinical and research laboratory settings.

Differentiator

Problem solved

Functional benefit

Brands

• iQuant: CLIA Analyzer developed in partnership with HTIC, IIT Madras for automated diagnostic testing.

Products and services

• CLIA Product Range Comprehensive Chemiluminescent Immunoassay (CLIA) test kits using proprietary Acridinium Ester-based chemistry for qualitative and quantitative detection of antibodies and antigens across multiple disease categories including infectious diseases, cardiac markers, hormones, tumor markers, and autoimmune conditions. Target customers: hospital laboratories, diagnostic chains, and reference labs in India and 40+ export markets.
• Rapid Test Kits Quick visual immunoassay test kits for point-of-care diagnosis of infectious diseases including Celiac, Chikungunya, COVID-19, Dengue, HBsAg, HCV, HIV, Leptospira, Malaria, Scrub Typhus, and Typhi. Results in 15-30 minutes with shelf life up to 30 months. Target customers: hospitals, clinics, primary health centers, and field screening programs.
• ELISA Test Kits Enzyme-linked immunosorbent assay (ELISA) kits for laboratory-based detection of antibodies and antigens for diseases including Celiac, Chikungunya, COVID-19, Dengue, HBV, HCV, HIV, Leptospira, Malaria, PCT, Scrub Typhus, Syphilis, and vitamins. Target customers: diagnostic laboratories and hospital labs requiring high-throughput quantitative testing.
• Confirmatory Test (HIV) Western blot-based confirmatory tests for HIV diagnosis following initial screening, providing definitive verification of HIV-1 and HIV-2 antibodies. Target customers: reference laboratories, blood banks, and HIV confirmatory testing centers.
• Blood Grouping Sera Monoclonal antibody-based blood typing reagents including Anti-A, Anti-B, Anti-D IgM, and Anti-AB sera for serological testing and blood group determination. Target customers: blood banks, hospital transfusion services, and diagnostic laboratories.
• Instrumentation Range Laboratory instruments including ELISA Reader and Washer, Fluorescence Instruments, and the proprietary iQuant CLIA Analyzer for automated chemiluminescent diagnostic testing. Target customers: diagnostic laboratories and hospitals running high-throughput immunoassay testing.
• iQuant CLIA Analyzer State-of-the-art automated and semi-automated chemiluminescence analyzer developed in partnership with HTIC, IIT Madras. Provides high-throughput, automated diagnostic testing capability for diagnostic laboratories running CLIA tests.
• Fluorescence Immunoassay Test Kits Fluorescence Immunoassay (FIA) test kits utilizing fluorescent labels for enhanced sensitivity in detecting various analytes. Target customers: diagnostic laboratories requiring high-sensitivity quantitative testing.

Quantifiable outcome

• 100% sensitivity per WHO evaluation for HCV TRI-DOT
• +3 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• HTIC, IIT Madras (Healthcare Technology Innovation Centre)coreTechnology or IntegrationPartnership with Healthcare Technology Innovation Centre at IIT Madras for development of the iQuant CLIA Analyzer. This state-of-the-art automated chemiluminescence analyzer represents indigenous technology development combining J. Mitra's diagnostic expertise with IIT Madras's research capabilities.
• International Agents NetworkcoreChannel Partner/ Reseller/ DistributorPartnership with local agents in 40+ countries for distribution of IVD products. Agents provide sales support, technical assistance, and ensure smooth supply chain operations for international markets.
• International Agencies and NGOscoreGTM or Marketing PartnerExport partnerships with international agencies and non-governmental organizations for supply of diagnostic kits to global health programs and humanitarian medical initiatives.
• GEM Portal (Government e-Marketplace)minorChannel Partner/ Reseller/ DistributorListing on Government e-Marketplace platform for direct engagement with government healthcare procurement systems in India.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/jmitraworld
• YouTubeyoutube.com/user/JMITRA1969
• Facebookfacebook.com/jmitraworld
• LinkedInlinkedin.com/company/jmitraworld

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about J Mitra & Co